heptakis(2,6-o-dimethyl)beta-cyclodextrin and mercaptoethanol

heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with mercaptoethanol in 1 studies

Compound Research Comparison

Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin)	Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin)	Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin)	Studies (mercaptoethanol)	Trials (mercaptoethanol)	Recent Studies (post-2010) (mercaptoethanol)
148	0	45	6,137	29	279

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asakawa, N; Ebine, K; Kawakami, Y; Murahashi, M; Narukawa, M; Nochi, S; Sato, T; Yokoyama, Y	1

Other Studies

1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and mercaptoethanol

Article	Year
Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810). Chemical & pharmaceutical bulletin, 1996, Volume: 44, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Cyclodextrins; Enzyme Inhibitors; Glutathione; H(+)-K(+)-Exchanging ATPase; Mercaptoethanol; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Sulfhydryl Compounds	1996

Article

Year

Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).

Chemical & pharmaceutical bulletin, 1996, Volume: 44, Issue:3

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; beta-Cyclodextrins; Chromatography, High Pressure Liquid; Cyclodextrins; Enzyme Inhibitors; Glutathione; H(+)-K(+)-Exchanging ATPase; Mercaptoethanol; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Sulfhydryl Compounds

1996